共 117 条
[1]
Suh S(2017)Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem Endocrinol Metab 32 180-1392
[2]
Park MK(2002)Mometasone furoate is a less specific glucocorticoid than fluticasone propionate Eur Respir J 20 1386-S439
[3]
Austin RJH(1998)Development of fluticasone propionate and comparison with other inhaled corticosteroids J Allergy Clin Immunol 101 S434-860
[4]
Maschera B(2000)Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma Journal of Allergy and Clinical Immunology 106 852-1236
[5]
Walker A(2000)Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers J Clin Pharmacol 40 1227-606
[6]
Johnson M(2009)Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice Immunopharmacol Immunotoxicol 31 601-237
[7]
Fish JE(2011)Fate of polymeric nanocarriers for oral drug delivery Curr Opin Colloid Interface Sci 16 228-1546
[8]
Karpel JP(2014)Is nanotechnology a boon for oral drug delivery? Drug Discov Today 19 1530-353
[9]
Craig TJ(2004)Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis Ann Rheum Dis 63 348-2074
[10]
Affrime MB(2015)Nanomedicine delivers promising treatments for rheumatoid arthritis Nanomedicine 10 2063-124